508 related articles for article (PubMed ID: 27326985)
1. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.
Sánchez J; Zakzuk J; Cardona R
J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Purohit A; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
[TBL] [Abstract][Full Text] [Related]
3. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
5. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Wan KS
J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
[TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy of Fexofenadine Versus Levocetrizine Versus Desloratadine via 1% Histamine Wheal Suppression Test.
Kc S; Aryal A; Adhikary M; Karn D
Kathmandu Univ Med J (KUMJ); 2020 Jan.-Mar; 18(69):19-22. PubMed ID: 33582682
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
10. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
Grob JJ; Lachapelle JM
Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
[TBL] [Abstract][Full Text] [Related]
11. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers.
Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R
J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762
[TBL] [Abstract][Full Text] [Related]
13. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
16. Antihistamines do not inhibit the flare induced by the intradermal injection of autologous plasma in chronic urticaria patients.
Asero R; Tedeschi A; Lorini M; Cugno M
Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):181-6. PubMed ID: 20128232
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L
Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218
[TBL] [Abstract][Full Text] [Related]
18. Antihistamines do not inhibit the wheal induced by the intradermal injection of autologous serum in resistant chronic idiopathic urticaria.
Magen E; Mishal J; Zeldin Y; Schlesinger M
Allergy Asthma Proc; 2012; 33(6):531-7. PubMed ID: 23394513
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
[TBL] [Abstract][Full Text] [Related]
20. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
